Tweet Patient and public involvement (PPI) has been the mantra in grant review and research funding for years. It is said that “People living with a health condition are often in a better position to know what questions remain unanswered about their treatment or condition, and what research would most likely improve their quality of…
Category: Multiple Sclerosis Research
I’ve got many things to be thankful for, but I’m not thanking MS yet
“Don’t thank me yet.” Whenever I use that phrase, I mean it in the way it’s traditionally meant. Whatever it is that you’re thanking me for isn’t complete, so wait until I’m done in case you’re not entirely thankful for the results. That’s how I’ve perceived the idiom for most of my life, but I’m…
Worsening Types
Tweet De Meo E, Addazio I, Portaccio E, Bonacchi R, Betti M, Patti F, Guerrieri S, Foschi M, Ferraro D, Annovazzi P, Brescia Morra V, Tortorella C, Lugaresi A, Camilli F, Pozzilli C, Perini P, Granella F, De Luca G, Torri Clerici VLAM, Vianello M, Romano S, Cocco EE, Lus G, Di Sapio A, Rocca…
With MS, holiday prepping is about shifting the bar, not lowering it
The holidays tend to arrive with a mix of excitement and stress, even for people without a chronic illness. But for those of us living with multiple sclerosis (MS), the season can feel like its own kind of marathon, full of expectations, overscheduling, symptoms that flare when we least want them to, and the pressure…
New MS research finds early immune activity in myelin cells
Oligodendrocytes, the cells that build and repair myelin in the brain and spinal cord, may play a role in the inflammatory processes involved in multiple sclerosis (MS), even at the earliest stages of disease, according to a study in a mouse model. “We found that oligodendrocytes transition to disease states already at early stages in…
Lower-dose contrast agent Vueway passes 3M doses
More than 3 million doses of Vueway (gadopiclenol), a lower-dose gadolinium contrast MRI agent used to diagnose and monitor conditions such as multiple sclerosis (MS), have been administered at more than 900 customer sites, maker Bracco Diagnostics said. Approved by the U.S. Food and Drug Administration for use in children and adults, ages 2 years and older,…
From our CEO
The post From our CEO appeared first on MS Australia. Source: www.msaustralia.org.au
Travel tips for people with MS: A comprehensive guide
The post Travel tips for people with MS: A comprehensive guide appeared first on MS Australia. Source: www.msaustralia.org.au
Helping healthcare providers support people with MS through exercise
The post Helping healthcare providers support people with MS through exercise appeared first on MS Australia. Source: www.msaustralia.org.au